Vijay Kedia acquires stakes in Mahamaya Lifesciences and SPML Infra
Ace investor Vijay Kedia increased his smallcap exposure in the March quarter by acquiring a 4.53% stake in Mahamaya Lifesciences and a 1.88% stake in SPML Infra. Kedia is recognized for identifying multibagger opportunities, and…